Intuitive Surgical ISRG
$452.80 −$15.72 (-3.36%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $453.85 +0.23%
Open$457.00
Prev close$468.52
Day range$450.51 – $463.25
Volume2.15M
Market cap$156.96B
P/E (TTM)54.8
Dividend yield–
Earnings
Average move on report day±6.0%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+13.9%
Worst reaction-14.1%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 20 Oct 2026 | After Market | ±6.9% | -2.26% | Within range |
| 2026/Q2 | 16 Jul 2026 | After Market | ±8.1% | -14.15% | Bigger than priced |
| 2026/Q1 | 21 Apr 2026 | After Market | ±7.1% | +7.16% | Bigger than priced |
| 2025/Q4 | 22 Jan 2026 | After Market | ±5.5% | -0.35% | Within range |
| 2025/Q3 | 21 Oct 2025 | After Market | ±7.3% | +13.89% | Bigger than priced |
| 2025/Q2 | 22 Jul 2025 | After Market | ±6.8% | -1.77% | Within range |
| 2025/Q1 | 22 Apr 2025 | After Market | ±7.9% | +1.92% | Within range |
| 2024/Q4 | 23 Jan 2025 | After Market | ±6.3% | -4.04% | Within range |
| 2024/Q3 | 17 Oct 2024 | After Market | ±6.8% | +10.01% | Bigger than priced |
| 2024/Q2 | 18 Jul 2024 | After Market | ±6.8% | +9.34% | Bigger than priced |
| 2023/Q4 | 23 Jan 2024 | After Market | ±5.4% | -0.36% | Within range |
| 2023/Q3 | 19 Oct 2023 | After Market | ±8.4% | -2.39% | Within range |
| 2023/Q2 | 20 Jul 2023 | After Market | ±6.9% | -3.16% | Within range |
| 2023/Q1 | 18 Apr 2023 | After Market | ±5.1% | +10.88% | Bigger than priced |
| 2022/Q4 | 24 Jan 2023 | None | ±5.6% | -5.50% | Within range |
| 2022/Q3 | 18 Oct 2022 | After Market | ±7.0% | +8.99% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q2
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$3.05B+21.7% YoY
Operating profit$1.04B+37.2% YoY
Net profit$524.40M-26.1% YoY
Diluted EPS$1.49-23.6% YoY
Free cash flow$1.11B+51.0% YoY
Operating cash flow$1.22B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin67.2%
Operating margin32.3%
Net margin25.5%
Return on equity18.0%
Return on assets15.3%
Return on invested capital16.3%
Current ratio3.33
Liabilities / assets16.7%
Cash & investments$4.04B
Net cash (debt)$4.04B
Free cash flow / sales31.1%
No comments yet — be the first to weigh in on ISRG.